查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631243

C型肝炎病毒(HCV)檢驗的全球市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2032年)

Hepatitis C virus (HCV) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 190 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著人們認識的提高、診斷技術的進步和積極的醫療保健舉措，全球丙型肝炎病毒 (HCV) 檢測市場規模正在持續增長。預計到 2025 年市場規模將達到 8.94 億美元，到 2032 年預計將成長至 13.267 億美元，複合年增長率為 5.80%。

市場概況HCV 檢測在識別和管理全球健康問題丙型肝炎感染方面發揮關鍵作用。此過程可檢測 HCV RNA 或抗體，從而實現早期介入和治療。先進的診斷技術，包括核酸和酵素免疫測定，可以進行準確、全面的檢測，是減少肝臟相關併發症的公共衛生策略的基石。

受丙型肝炎盛行率上升、診斷技術的進步和積極的醫療對策的推動，HCV 檢測市場預計將經歷顯著增長。領先公司的策略性舉措和對早期檢測的關注預計將為全球管理 HCV 感染提供有效的解決方案，從而推動市場發展。隨著不斷進步，預計該市場將在全球醫療保健中發揮重要作用。

本報告提供全球C型肝炎病毒(HCV)檢驗市場相關調查，提供市場概要，以及技術，各檢驗類型，各終端用戶，及各地區趨勢，及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
  • 價值鏈分析
  • 波特的五力分析
  • COVID-19影響分析
  • 烏克蘭·俄羅斯糾紛的影響
  • 經濟概要
  • 大環境分析

第3章 2024年的價格分析

第4章 全球C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

  • 全球C型肝炎病毒(HCV)檢驗市場預測，技術，金額(10億美元)，數量(事)，2019年～2032年
  • 全球C型肝炎病毒(HCV)檢驗市場預測，各檢驗類型，價值(10億美元)，2019年～2032年
  • 全球C型肝炎病毒(HCV)檢驗市場預測，各終端用戶，價值(10億美元)，2019年～2032年
  • 全球C型肝炎病毒(HCV)檢驗市場預測，各地區，價值(10億美元)，數量(事)，2019年～2032年

第5章 北美的C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

第6章 歐洲的C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

第7章 亞太地區的C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

第8章 南美的C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

第9章 中東·非洲的C型肝炎病毒(HCV)檢驗市場預測，2019年～2032年

第10章 競爭情形

  • 企業市場佔有率分析，2024年
  • 競爭儀表板
  • 企業簡介
    • OraSure Technologies, Inc.
    • Abbott Laboratories Inc.
    • Siemens Healthcare GmbH
    • Bio Rad Laboratories Inc.
    • Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
    • Bayer AG
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
    • BioGenex
    • AccuQuick,
    • Roche Diagnostics (F. Hoffman-La Roche Ltd.)
    • STD Rapid Test Kits

第11章 附錄

簡介目錄

The global Hepatitis C Virus (HCV) testing market is witnessing consistent growth, fueled by rising awareness, advancements in diagnostic technologies, and active healthcare initiatives. By 2025, the market is expected to reach 894 million, with projections indicating a rise to 1,326.7 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.80%.

Market Overview HCV testing plays a vital role in identifying and managing Hepatitis C infections, a major global health concern. The process involves detecting HCV RNA or antibodies, enabling early intervention and treatment. Advanced diagnostic techniques, including nucleic acid and enzyme immunoassays, ensure accurate and comprehensive testing, making it a cornerstone in public health strategies to reduce liver-related complications.

The HCV testing market is poised for significant growth, driven by the rising prevalence of Hepatitis C, advancements in diagnostic technologies, and proactive healthcare measures. Strategic actions by major players and a focus on early detection are expected to drive the market forward, providing effective solutions for managing HCV infections globally. With continuous advancements, the market is positioned to play a critical role in global healthcare.

Key Market Drivers

  • 1. Increasing Hepatitis C Prevalence: The global rise in Hepatitis C infections has heightened the demand for accurate diagnostic methods. High-risk groups, such as individuals exposed to unsafe medical practices and intravenous drug users, underscore the importance of effective testing solutions.
  • 2. Technological Innovations: Breakthroughs in diagnostic technology, such as polymerase chain reaction (PCR) and advanced immunoassays, have improved the sensitivity and accuracy of HCV testing, encouraging wider adoption.
  • 3. Government and Awareness Campaigns: Efforts by governments and healthcare organizations to combat infectious diseases have boosted the uptake of HCV testing. Awareness programs highlighting early detection and treatment further drive market growth.

Opportunities for Growth The shift towards preventive healthcare and routine screenings creates lucrative opportunities for market participants. Increased investment in public health campaigns has made HCV testing a standard part of health evaluations, expanding its accessibility. Additionally, the adoption of point-of-care testing (POCT) technologies offers faster and more convenient diagnostic options in various healthcare settings.

Regional Insights

  • 1. Asia Pacific: This region holds the largest market share, driven by a large population base and significant prevalence of Hepatitis C infections. Enhanced healthcare infrastructure and supportive government initiatives further fuel market growth.
  • 2. Middle East & Africa: Expected to grow the fastest, this region faces unique infectious disease challenges. Investments in healthcare infrastructure and early diagnostic initiatives are fostering market expansion.
  • 3. North America and Europe: These regions exhibit steady growth due to advanced healthcare systems, widespread adoption of diagnostic technologies, and heightened public awareness.

Leading Market Players Key companies shaping the HCV testing market include:

  • Abbott Laboratories Inc.
  • Siemens Healthcare GmbH
  • Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • Bio-Rad Laboratories Inc.
  • OraSure Technologies, Inc.
  • Bayer AG
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics Inc. (Johnson & Johnson)

These industry leaders employ strategies such as technological advancements, strategic partnerships, and awareness campaigns to strengthen their market positions. For instance, Abbott Laboratories' ARCHITECT anti-HCV immunoassay and Roche Diagnostics' PCR-based assays highlight their dedication to providing precise and reliable diagnostic solutions.

Market Segmentation

1. By Technique:

    Immunoassays-based Hepatitis C Virus Testing Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing Other Testing Techniques

2. By Test Type:

    HCV Antibody Testing HCV Viral Load Testing HCV Genotyping Testing

3. By End User:

    Hospitals Diagnostic Centers Blood Donation Centers

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hepatitis C virus (HCV) Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume (Units), 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2024

  • 3.1. Global Average Price Analysis, by Technique, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Hepatitis C virus (HCV) Testing Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 4.1. Global Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 4.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 4.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 4.2. Global Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. HCV Antibody Testing
      • 4.2.1.2. HCV Viral Load Testing
      • 4.2.1.3. HCV Genotyping Testing
  • 4.3. Global Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Diagnostic Centers
      • 4.3.1.3. Blood Donation Centers
  • 4.4. Global Hepatitis C virus (HCV) Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 5.1. North America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 5.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 5.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 5.2. North America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. HCV Antibody Testing
      • 5.2.1.2. HCV Viral Load Testing
      • 5.2.1.3. HCV Genotyping Testing
  • 5.3. North America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Diagnostic Centers
      • 5.3.1.3. Blood Donation Centers
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. U.S. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. Canada Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. Canada Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 6.1. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 6.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 6.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 6.2. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. HCV Antibody Testing
      • 6.2.1.2. HCV Viral Load Testing
      • 6.2.1.3. HCV Genotyping Testing
  • 6.3. Europe Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Diagnostic Centers
      • 6.3.1.3. Blood Donation Centers
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. Germany Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. U.K. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. U.K. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. France Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. France Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. Italy Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. Italy Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Turkey Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Turkey Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Russia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Russia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.19. Rest of Europe Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.21. Rest of Europe Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 7.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 7.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 7.2. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. HCV Antibody Testing
      • 7.2.1.2. HCV Viral Load Testing
      • 7.2.1.3. HCV Genotyping Testing
  • 7.3. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Diagnostic Centers
      • 7.3.1.3. Blood Donation Centers
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. China Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Japan Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Japan Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. South Korea Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. South Korea Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. India Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. India Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.13. Southeast Asia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.15. Southeast Asia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 8.1. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 8.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 8.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 8.2. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. HCV Antibody Testing
      • 8.2.1.2. HCV Viral Load Testing
      • 8.2.1.3. HCV Genotyping Testing
  • 8.3. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Diagnostic Centers
      • 8.3.1.3. Blood Donation Centers
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. Brazil Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. Mexico Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. Mexico Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Argentina Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Argentina Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Rest of Latin Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 9.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 9.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 9.2. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. HCV Antibody Testing
      • 9.2.1.2. HCV Viral Load Testing
      • 9.2.1.3. HCV Genotyping Testing
  • 9.3. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Diagnostic Centers
      • 9.3.1.3. Blood Donation Centers
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.3. GCC Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.4. South Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.6. South Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.7. Egypt Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.9. Egypt Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.10. Nigeria Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.12. Nigeria Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. OraSure Technologies, Inc.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Technique Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Abbott Laboratories Inc.
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Technique Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Siemens Healthcare GmbH
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Technique Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. Bio Rad Laboratories Inc.
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Technique Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Technique Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Bayer AG
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Technique Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. QIAGEN N.V.
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Technique Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Thermo Fisher Scientific Inc.
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Technique Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. BioGenex
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Technique Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. AccuQuick,
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Technique Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Technique Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. STD Rapid Test Kits
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Technique Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations